["{\n\"step_by_step_thinking\": \"The major aim of Phase I clinical trials is to establish a maximum tolerated dose (MTD) and a tolerable dose range for future efficacy testing. This information can be found in the document 'Phase I cancer trials: limitations and implications'. According to this document, the goal of Phase I clinical trials is to determine the MTD and tolerate dose range.\",\n\"answer_choice\": \"C\"\n}"]